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ABSTRAC'l'

Behavior is under the control of external and internal
stimuli.

The emis sion of behavior is therefore most efficient

when the stimulus-conditions similar to those under which the
behavior was acquired are reinstated.

Amphetamine was shown

to produce a "stimulus-state" which controlled behavior.

A

decrement in response strength occurred when a response acquired
under the influence of amphetamine was emitted in the absence
of amphetamine or in the presence of no-drug.

The response

strength recovered when the amphetamine-state was reinstated.
Rats were trained to jump to a wooden platform from an
electrifiable grid-floor, in order to avoid shock.
was used as the conditioned stimulus.
to elapse between testing and training.

A buzzer

Seven days were allowed
A conditioned avoid-

ance response acquired under the influence of amphetamine was
emitted without decrement under 1) 2.0 mg amphetamine per kg
body weight, 2) 100 or 400 mg dl-3,4-dihydroxyphenylalanine
per kg body weight, 3) 50 mg dl-

(;~

-methyl-p-tyrosine per kg

body weight, 100 or 400 mg dl-3,4-dihydroxyphenylalanin c per
kg body weight and 2.0 mg amphetamine per kg body weight, 4)

-iii-

316 mg

parachloro~1enylalanine

per kg body weight, 75 mg dl-5-

hydroxytryptophan per kg body wcj 0Jit and 2. 0 mg c.1mplletaminc
per kg body weight.
However, the per cent avoidance deteriorated markedly
(all comparisons were statistically significant), when subjects
trained under amphetamine were tested after pretreatment under

1) no injections, 2) dl-C!-methyl-p-tyrosine and amphetamine,
3) parachlorophenylalanine and amphetamine, 4) hydroxyamphetamine (10 mg/kg or 30 mg/kg), 5) chlorpromazine (1 or 4 mg/kg)
and amphetamine, 6) cyproheptadine (10 mg/kg) and amphetamine.
Moreover, animals treated chronicc1lly with amphetamine, when
trained under amphetamine, showed a decrement in responsestrength when tested under no-drug.
A conditioned-avoidance response acquired under the influence of hydroxyamphetarnine (30 mg/kg) was emitted without
decrement in response strength under either hydroxyamphetamine
or no-drug.

Further, a conditioned avoidance response acquired

under the influence of rJ.-methyl-p-tyrosine and amphetamine
was emitted without decrement in response strength under either

c,~-methyl-p-tyrosine and amphetamine or just amphetamine.
These studies suggest that there exists a stimulus-stat e
associated with amphetamine and that this behnvior-controlling

-iv-

state is not the result of the
The drug-interaction
chol ~mines

f:t

stuJic·~;

imulant property of the c1ru9.
!'";uggc.sl thcil ccnlr<il. catc-

and 5-hydroxytryptamine are involved in the

arnine-state.

am~1et

Further, by varying the concentration of either

amine, the amphetamine-state may be altered.
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I.

INTRODUCTION

Recent experiments have demonstrated that drugs, acting
on the brain, may also serve as discriminative stimuli.

A

rat may learn to make a certain choice in a maze if it is
injected with one drug and a second choice if it is tested
with no drug (Overton, 1964, 1966).

The learning associated

with a drug-state may have important implications to humans.
New behaviors, acquired via behavior modification, under the
influence of a drug may not be reproduced without benefit of
the drug.
Amphetamine, which has recently been shown to produce
state-dependent learning (Lal, 1969), has been shown to release
central norepinephrine (Glowinski et al., 1966b; Carr and
Moore, 1969) and 5-hydroxytryptamine (Beauvallet et al., 1969).
Moreover, 5-hydroxytryptophan, a precursor of 5-hydroxytryptamine, has also been shown to cause a release of norepinephrine
in vivo (Brodie et al., 1966) and in
1963).

vitr~

(Carlsson et al.,

In addition, recent evidence indicates that 5-hydroxy-

tryptamine acting through norepinephrine may be responsible
for raising the thre s hold necessary for shoe}: induced fighting
(Lal et al. , 1969).

5

The present invcstigution sought evidence to establish:

1)

A behavioral ccntrolling

am~1etamine-state

in rats using

a learning criterion which is weaker than that used
previously in mice.
2)

That the learning associated with the amphetamine-state
is not the result of either the stimulant property of the
drug or the novelty of the drug stimulus.

3)

That the amphetamine-state is due to a central action of
amphetamine.

4)

The role or roles of norepinephrine and/or 5-hydroxytryptamine in the amphetamine-st ate.

5)

Whether hydroxyamphetamine, a drug which has only peripheral
actions (Innes and Nickerson, 1965) produces state-dependent
le~rning.

II.

Learning

As~ociated

LITEI<ATURE SURVEY

with a Drug-State.

Learning associated with a drug-state has been demonstrated
in a number of procedures.
Utilizing pole-climbing avoidance, Otis (1964) demonstrated
that chlorpromazine-trained animals showed a decrement in
avoidance when tested with saline but not with chlorpromazine.
Similarly, saline-trained animals showed a decrement in avoidance when tested with chlorpromazine but not with saline.
Utilizing pit avoidance, Lal (1969) demonstrated that
amphetamine-trained animals showed a decrement in avoidance
if tested with either chlorpromazine or saline .

Similarly,

chlorpromazine trained animals showed a decrement in avoidance
when tested with either amphetamine or saline.
Overton (1964), utilizing at-maze, demonstrated that
phenobarbital-trained animals showed a decrement in responding
when te sted under no-drug.

He also demonstrated response

control in at-maze using pentobarbital and no-drug (19 64),
pentobarbital and saline (1964), phenobarbital 0nd saline (=.)60),
atropine and saline (1966), and
(1966).

chlorprom~tzine

and phenobarbital

However, he could not obtain response control under

7

either gallamine or tetraethylammonium and saline (1964).
These latter results indicate that the response control by
the barbiturates was not due to either muscle flaccidity or
an autonomic blockade.
Utilizing a two-operant schedule, one under the control
of positive reinforcement of food and the other under the
control of shock avoidance, Kubena and Barry (1969) demonstrated that rats would elicit the same response for high
doses of alcohol, pentobarbital, chlordiazepoxide and chloral
hydrate in each procedure.
Utilizing a schedule of positive reinforcement, Belleville
(1964) demonstrated that rats trained to bar-press for food
under saline, amphetamine, or morphine made a greater number
of responses during extinction, if they received the same drug
that was administered during acquisition.

Roffman and Lal

(1969)demonstrated that rats, trained to bar-press for water,
would make a greater number of responses during the second
session of extinction if they had amphetamine on the first
extinction session.
Learning associated with a drug-state can thus be demonstrated by the use of either positive or neg at ive reinforce r·a nt .
Further, stimulants and depre ssan ts, neurona l blocker s and
narcotic analgesics are some of the classes of drugs that
produce state-dependent learning.

Relationship Be tween

l\mphetami~e

a!1d Noreoinephr ine

Amphetamin e , which has recently been demonstrated to
cause a decrease in the level of brain norepinephrine in
fighting mice {Welch and Welch, 19 67 ), has been shown to
cause a striking elevation in the level of plasma catecholamines (Harvey et al., 1968).

Moreover, after the injection

of H3 -norepinephrine into the lateral cerebral ventricle of
cats, Carr and Moore (1969) noted that the addition of damphetamine to the venlricle perfusion fluid caused a significant increase in the conc entrati on of H 3 -norepinephri ne
and normetanephrine in the effluent of the perfusion fluid.
These studies indicate th at norepinephrine may be involved
in the action of amphetamine.
Utilizing various behavioral tests, Weissman et El:_.
(1966} noted that

(~-methyl-p-tyrosine,

an

inhibitor of

norepinephrine synthesis (Spe cto r et al., 1965} antagonizes
the hyperactivity, the sniffing-licking-gnawi ng syndrome
and the anorexia producted by amphetamine.

Since the amount

of ~~-methyl-p-tyrosine which antagonizes the amphetamine
stimulation had no effect o n the basal level of behavioral
performance , Weissman proposed that newJ.y synthesized norepjnephrine was essential for the action of amphetamine.

How-

ever, both amphetamine and 3,4-dihydroxyphenylalanine have
recently l.)ecn shown to reverse the behci.viora l depression of

9

a conditioned avoidance respon se caused by d-methyl-p-tyrosine
(Moore and Rech, 1967).

These results indicate that the action

of amphetamine may be more complex than proposed by Weissman.
Amphetamine has been shown to cause an elevation in the
levels of H3 -normetanephrine (Glowinski et al., 1966a), that
is, prevent the reuptake of extra-neural norepinephrine by
the nerve ending.

This study suggests that amphetamine's

action consists of blocking the reuptake into the neuron of
released norepinephrine.

Relationship Between Catecholamines and 5-Hydroxytryptamine
Vogt (1954) has demonstrated that norepinephrine is
dis tributed in the brain in a manner similar to 5-hydroxytryptamine, being the highest concentration in the brain stem
and absent from the cerebellum.

The 5-hydroxytryptamine has

been shown to release norepinephrine in vitro (Carlsson et al.,
1963).

Carlsson et al.

(1957) also demonstrated that 5-

hydroxytryptophan and 3,4-dihydroxyphenylalanine would reverse
the sedative effect of reserpine greater than either of the
drugs used above.

Moreover, Brodie et al.

(1966) demonstrated

that the intravenous injection of 5-hydroxytryptophan lowered
brain norepinephrir1e levels by 50 per cent in rats _a nd rabbit s
and elicited increased motor activity, piloerection, and
panting.

Recently Lal et al.

(1969) postulC'lted that 5-hydroxy-

10
tryptamine , acting through catecl1olamines, was responsible
for amphetamine-induced elevation of the shock level necessary
to elicit fighting.

These studies suggest the the action of

one amine may be mediated by the other amine in the central
nervou s system.

III.

EXPERI.MEN"TAL

Chemicals
Chemicals used were analytical grade or equivalent.
Hydroxyarnphetamine Sulfate, Dextroamphetarnine Sulfate and
Chlorpromazine Hydrochloride were obtained through the courtesy
of Smith, Kline and French Labs., Philadelphia, Pennsylvania.
Reserpine (Serpasil Phosphate) and Syrosingopine were obtained
through the courtesy of CIBA Pharmaceutical Company, Summit,
New Jersey.

Parachlo rophenylalanine was obtained through the

courtesy of Chas. Pfizer & Co. Inc., Groton, Connecticut.
Cyproheptadine was obtained through the courtesy of MerckSharp and Dohme Research Laboratories, West Point, Pennsylvania.
dl-3,4-dihydroxyphenylalanine (Dopa) was obtained from
CALBIOCHEM, Los Angeles, California and from Mann Research
Labs., New York, New York.

dl- ,l-methyl-p-tyrosine was obtained

from Regis Chemical Company, Chicago, Illinois.

The dl-5-

hydroxytryptophan was obtained from Aldrich Chemical Company,
Cedar Knolls, New Jersey.

All drugs were dissolved in distilled

water except <il.-niethyl-p-tyros ine and dl-3, 4-dihydroxyphenyla lanine, which was suspended in 0.5 per cent carboxymethylcellulose, and parachlorophenylalanine, which was dissolved
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according to the procedure of Koe and Weissman (19 66) .

Animals
Male and female albino rats of Sprague-Dawley strain ,
random-bred, weighing 200-400 gms., were obtained from Charle s
River Breeding Farms, Wilmington, Massachusetts.

Some of the

rats had been used in other behavioral and toxicological
experiments prior to their use in this investigation.

How-

ever, there was at least an interval of one week between other
experiments and the training of the animals for this study.

Conditioning and Testing
Training consisted of placing a rat on an electrifiable
grid floor of an aluminum chamber (8 in. x 10 in. x 9 in.)
containing a wooden platform (4 in. x 6 in. x 2 in.).

The

conditioned stimulus (CS), a buzzer of fifty-eight decibels,
was turned on a s soon as the rat was placed in the chamber
and then maintain ed for ten seconds.

Responding to th e CS

with a jump (CR) onto the wooden platform termin ated t he trial.
Failure to r espond with a conditioned response resulted in a
continuous scrambled foot shock of one milliampere from a
Grason-Stadler Shocker, model number El064GS.
maintained until

Cl

jump to escape was made.

second inter t ri al interval .

The shock was
There was a thirty

The learning criterion, achieved
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in a single ses son , consisted of
during ten consecutive trials.

~ight

avoidnnce-responscs

Animals which did not reach

criterion by thirty trials were not included in the study.
After the learning trials, the subjects were returned to home
cages for seven days.

Testing for retention occurred seven

days after the last acquisition trial.
The criterion for learning associated with the drug-state
consisted of a significant decrement in responding when the
drug or drugs, used in the retention test, produced stimulusconditions dissimilar to those which occurred during acquisition.

Statistics
All statistical tests, for groups having more than ten
rats, were compared using the Chi-square Analysis (Snedecor
and Cochran, 1967).

Whenever, the group contained less than

ten rats, the Exact method of significance {Goldstein, 1967)
was used to compare P values.
Unless otherwise stated, a comparison of the per cent
avoidance, during performance, to the per cent avoidance of
the next to last acquisition trial conducted seven days prior
to performance is included in the tables.
priate, within-groups

comp~risons

Wherever

appro-

are stated in the text.

IV.

RESULTS

Quantitation of an Amphetamine-Produced "Stimulus-State"
In order to determine the lowest dose capable of producing
the amphetamine-state, animals were trained with various do s es
of amphetamine and tested seven days l<:i.ter under the same dose
of the drug or under no-drug.
Data summarized in Table

I

indicate that animals traine d

under 0 (ND-ND), 0.5 (A_ -A_ ) or 1.0 (A _ -A _ ) mg amphet5
5
1 0 1 0
amine per kg body weight showed a significant decrement in
avoidance when tested under the same dose of drug.

No differ-

ence in per cent avoidance during performance is seen if nodrug-trained and no-drug-tested (ND-ND) anima ls are compared
to animals trained and tested under 0.5 mg or 1.0 mg amphetamine per kg body weight (ND-ND vs A
P )' . 05) .

weight

0.5

-A

0. 5

or A

1.0

-A

1 .o

,

Animals trained under 2. 0 mg amphetamine per kg body

showed no

decrement in avoidance when tested under

a similar dose of the drug,

(A

2.0

-A

)

2.0 .

However, these

animals showed a decrement in avoida nce when tested under nodrug,

(A

2.0

-ND).

No-drug-tr a in e d animals showed no dec rement

in avoidance when te s ted under 2.0 mg amph e ta mi ne per kg bo dy
weight,

(!\TD-A _ ).
2 0

Perform;1nce of these a n ima ls was signifi-

15

cantly higher than the perforn101nce of the animals trained
under 2.0 mg amphetamine per kg body weight and tested under
no-drug,

(ND-A

2. 0

vs A

2.0

-ND, P ( .05).

In order to determine the number of tests which could
resp~nse,

be performed prior to extinct ion of avoidance

amphetamine-trained animals were given repeated tests under
amphetamine or no-drug.

Similarly, no-drug-trained animals

were given repeated tests under no-drug and amphetamine.
Amphetamine-trained animals showed significantly higher
avoidance in all four tests than either amphetamine-trained
animals tested under no-drug or no-drug-trained animals tested
under no-drug,

( Figure 1

A-A
I

vs ND-ND _ , P
1 4

<C.05).

1-4

vs A-ND

1-4

P

( . 01 · A-A

I

I

1-4

No-drug-trained animals tested under

no-drug demonstrated significantly higher avoidance in three
of the four tests than amphetamine-trained animals did when
tested under no-drug {ND-ND

1,3,4

vs A-ND

1,3,4

, P cf! • 01).

Testing amphetamine-trained animals under amphetamine, resulted
in similar avoidance during the first three tests as did the
no-drug-trained animals tested under amphetamine,
A-A

1 2 3
I

I

vs ND-A

1,2,3

, P

~

.05).

(Figure 1,

However, during the last test

tria 1 the subjects trained and tes.ted und er amphetamine showed
significantly lower avoidance than those trained under no-drug
but tested under amphetamine,

(A-A

4

vs ND-A , P ...- .05).
4
~
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The Effect of Amphetamine on the Acquisition and
Performance of a Conditioned Avoidance Response.
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~ .05 level) FrLln the
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TABLE I

EFFECT OF AMPHETAMINE ON PERFORMANCE OF CONDITIONED AVOIDANCE RESPONSES

Drug~ (mg/kg) 1

Group

A
A
A
A
A

.5

-A

1.0
2.0
2.0
2.0

ND-A

.5

-A
-A
-A

1.0
2.0
1.0

-0.TD

p

Acquisition vs Performance

Acquisition

Performance

Amphetamine 0.5

Amphetamine 0.5

14

27

~ .01

AMphetamine 1.0

Amphetamine 1.0

15

40

~- 01

Amphetamine 2. 0

Amphetamine 2.0

15

80

N oS.

Amphetamine 2.0

Amphetamine 1.0

14

27

~.

Amphetamine 2.0

No Drug

28

36

4'.. 05

10

90

N.S.

39

55

N.S.

-

No Drug

-

Amphetamine 2.0

No Drug

-

No Drug

2.0

ND-ND

%
Avoidance

-

1 30 min.
i •P • prior to performance.
2
93% avoi da nce during last acquisition trial.

N

2

01

I

f-'
'1
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Amphetamine-trained animals, which were given four tests
under amphetamine (Table II, A-A

1-4

) and did not show any

decrement in avoidance, showed a significant decrement on
the first no-drug test

No-drug-trained

(Table II, A-ND ) .
1

animals, which showed no decrement in avoidance in any of the
four amphetamine tests (Table III, ND-A

1-4

), showed a decre-

ment in avoidance on the first no-drug test

(Table III, ND-ND ).
1

Per cent avoidance of no-drug-trained animals, when tested
under amphetamine on the first drug-test, was not significantly
different from the performance under amphetamine on the second,
third or fourth drug-test
P

~

. 05) .

(ND-A

1

vs ND-A , ND-A or ND-A ,
3
4
2

Similarly, performance of no-drug-trained animals,

tested under no-drug on the fir s t drug-test, did not diff er
from similarly train ed animals, te st ed under no-d rug on the
second, third, or fourth test (ND-ND
ND-ND , P
4

> .05).

1

vs ND-ND , ND-ND or
2
3

In addit io n no significant difference in

per cent avoidance is seen when amphetamine-trained animals,
tested under amphetamine on the fir s t drug-test, are compared
to similarly trained anima l s tested under amphetam ine on the
second, third and fourth drug test
A-J\ , P :;it .05).
4

(A-A

1

vs A-A

2'

A-A

While no further deteriorc1tion in

or

3

perform c-:1.~e

was seen when amphetamine-trnined animals are tested under
no-drug on the fir st and on the second drug-test

(A-ND

1

vs

TABLE II

EFFECT OF AMPHETAMINE ON CONSECUTIVE CONDITIONED AVOIDANCE
RESPONSES ACQUIRED UNDER AMPHETAMINEl

Treatment Prior to
Performance

Group

N

%
Avoidance

p

Acquisition vs Performance

TEST l
No Drug
Amphetamine 2

A-ND
1
A-A
1

28
18

36
88

,.01
N. S.

37
78

~.

0
76

~.01

TEST 2
No Drug
2
Amphetamine

A-1\TD
2
A-A

8
18

01
N. S.

1

TEST 3
No Drug
Amphetamine 2

A-ND
A-A 3
3

10
33

N .S.

TEST 4
No Drug
2
Amphetamine

A-ND
A-A 4
4
1
2

14
10

0
60

"· 01
N .S.

~

1.0

2.0 mg/kg, i •P•
2.0 mg/kg, i •P

k11 11

I

•I

30 min prior to acquisition trials.
30 min prior to performance tests.

TABLE III
EFFECT OF AMPHETAMINE ON CONSECUTIVE CONDITIONED AVOIDANCE
RESPONSES ACQUIRED UNDER NO DRUG

Treatment Prior to
Performance

Group

!\TD-ND
ND-A l
1
ND-ND
2
ND-A
2
I:\TD-ND
l'ill-A

3

3
I\1:>-~1D 4

!\TD-A
1

2

4

N

%
Avoidance

p

Acquisition vs Performance

No Drug
1
Amphetamine

TEST 1
39
10

55
90

". 05
N.S.

No Drug
1
Amphetamine

TEST 2
19
37

37
79

L.01
N .S.

No Drug
1
Amphetamine

TEST 3
27
17

41
82

£.01
N. S.

No Drug
Amphetamine

TEST 4
27
17

22
78

~-

2

01
N. S.

2

3

3

2.0 mg/kg, i .p. , 30 min prior to performance.
95% avoidc,nce during next to last acquisition trial.

N

0

3 93% avoidance during next to last acquisition trial.

21

r

A-ND , P
2

.05), a significant difference

W<lS

seen when

amphetam i ne-trained animals, tcslcd under no-drug on the first
drug-test, are compared to similarly trained animals, tested
under no-drug on the third and on the fourth drug tests (A-ND
vs A-ND 3

I

A-ND 4

I

p

1

~ .05).
c,,..

Localization of Stimulus-State
In order to determine whether the amphetamine-state is
due to the peripheral or central effects of amphetamine,
hydroxyamphetamine was used.

Hydroxyamphetamine is an amphet-

amine-like drug which does not penetrate the central nervous
system (Innes and Nickerson, 1965).

Data presented in Table

IV show that animals trained and tested under 10 mg hydroxyamphetamine per kg body weight showed a decrement in avoid ance
(OHA

10

-OHA

10

).

However, testing animals trained under 30 mg

hydroxyamphetamine per kg body weight under either a similar
dose of the drug or no-drug resulted in no decrement in
avoidance.

On the other hand, amphetamine-trained animals

showed a decrement in avoidance when tested under either dos e
of hydroxyamphetamine.

Role of Amphetamine's Stimulant Propert:t_
If animals, tested under amphetamine, were emitting higher
avoidance due to the stimulotory property of amp"!letamine, then
anim~ls

trained to a weaker criteria should

demonst~ate

TABLE IV
EFFECT OF HYDROXYAMPHETAMINE ON CONDITIONED AVOIDANCE RESPONSES
ACQUIRED UNDER HYDROXYAMPHETAMINE OR AMPHETAMINE

%

Drug(mg/kg)l
Acquisition
Performance

Group

Avoidance

N

p

Acquisition vs Performance

A-A

Amphetamine

2

Amphetamine

2

8

88

N. S.

:t\1D-ND

No Drug

-

No Drug

2

39

55

£ .o5 2

A-OHAlO

Amphe tamine

2

Hydroxy10
amphetamine

10

20

l-01

A-OI-LA

Amphet;:imine

2

Hydroxy30
amphetamine

12

8

!. 01

-

Hydroxy10
amphetamine

Hydroxy10
amphetamine

12

50

-

30
Hydroxyamphetamine

Hydroxy30
amphetamine

9

88

N .S.

O.HA 30-

Hydroxy30
amphetamine

No Drug

9

66

N.S.

OHA

30

OHAlO

10
OI-it-\
OH.i\ 30

l

.05

30
~11)

-

130 min prior to performance.
2
95% avoid~Dce during last acquisition trial.

,i I

IV
N
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amphetamine-induced improvemc n t

in

performc:rnce.

improvement in per cent avoidance should occur in

A s ig !L:. f ica nl
ani . m~ls

trained to either criteria when no-drug-trc:iined animals are
tested under amphetamine.

The data summarized in Table V

indicate that animals trained to a weaker criteria di.d not
show an improvement in avoidance when tested under amphetamine.
Animals trained to the stronger criteria under no-drug showed
a decrement in avoidance, when tested under either dl-3,4dihydroxyphenylalanine or no drug.

However , these animals

showed no decrement in avoidance when tested under amphetamine.
No difference, in per cent avoidance, is seen between animals,
trained to the weaker criteria and tested under amphetamine
and those tested under no-drug.

A significant difference in

per cent avoidance is seen between animals, trained to a
stronger criteria and tested under amphetamine, and those
tested under no-drug or dl-3,4-dihydroxyphenylalanine.
In order to determine if avoidance was due to random
jumping off the grid, due to the central nervous system
stimulatory effect of amphetamine, random jumping was measured.
Data in Table VI show that amphetamine was unable to cause
random jumping off the grid.

Drug-St _~~1lu~_<:.'._~a

Nove!:__~ric:~~

In orde r to determine if learning associated with the
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TA BLE VI
)'

EFFEC'I' OF AMPHETAMINE OF JUMPING OFF THE GRID BY RATS

p

Treatment

N

% Jumping

Drug vs Control

No Drug

19

0

N.S.

Saline 1

9

11

N.S.

131

3

Amphetamine 2
I

1 1 mg/kg, i. p.,

2

30 min prior to trial.

2.0 mg/kg, i.p., 30 min prior to trial.
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amphetamine-state is due to a novel drug-stimulus, amphetamine
was injected chronically to a group of rats.

These c:tnimals,

when trained under no-drug, did not show any decrement in per
cent avoidance when tested under amphetamine or no-drug
(ND c -A

I

ND-ND

I

Table VII).

A decrement in avoidance was seen

in order chronically treated animals when trained under
amphetamine and tested under no-drug (Tab le VII, A -ND ).
c
Similarly treated and trained animals showed no decrement in
avoidance when tested under amphetamine (A -A) •
c
Effect of Selected Drugs on Conditioned

Avoidan~e

Response

Since drug-interactions will be used to determine the
role of amines in the amphet amine -st ate , each drug was tested
for its acute effects on a newly acquired conditioned
avoidance response.

Data pre sented in Table VIII indicate

that animals tested under 5-hydroxytryptophan and 4.0 mg
chlorpromazine per kg body weight caused a decrement in per
cent avoidance of a conditioned avoidance response.

Animals

tested under reserpine, dl-3,4-dihydroxyphenyla l anine , dl-5hydroxy tryptophan and amphetamine also showed a decrement in
avoida nce of a conditioned avoidance response .

Animals tested

under amphetamine , reserpine, atropine, chlorprom.:izine (1.0),
syrosingopinc , cyprohcptudine, hydroxyphenyla la nine, or dlmethyl-p-tyrosine

s~1owed

t·! -

no decrement in per cent avoidance.

TABLE VII
EFFECT OF CHRONIC AMPHETAMINE TREATMENT 1 ON CONDITIONED AVOIDANCE
RESPONSES ACQUIRED AND TESTED UNDER AMPHETAMINE 2

Group

A -A
c
c
A -ND

c

c

ND -A
c
c
ND -ND

c

1

c

Acquisition 3

Druq
Performance

N

%
Avoidance

p

Acquisition vs Performance

Amphetamine

Amphetamine

18

88

N. S.

Amphetamine

No Drug

18

55

t!. 05

No Drug

Amphetamine

16

68

N.S.

No Drug

No Drug

16

68

N .S.

1 days prior to acquisition and during the 6 day acquisition-performance interval.

2 2.0 mg/kg, i.p., 30 min prior to performance.
3Amphetamine not administered 24 h prior to acquisition and prior to performance
and 24 h after acquisition.
N
-.]

TABLE VIII
EFF ECTS OF VARIOUS DRUGS ON A NEWLY-ACQUIRED CONDITIONED AVOIDANCE RESPONSE

Dose
(mg/kg)

Dr u g

N

%
Avoidance

p

Acquisition6 vs Performance

-l

5.0

8

75

N.S.

3.0

8

100

N. S .

400.0

13

93

N.S.

75.0

12

33

I.. 05

1.0
4.0

8

10

100
0

e. 01

Cyproheptadine 5

10 . 0

8

100

N.S .

d ,__ c:-Methyl-p-tyrosine 6

50.0

8

100

N. S .

2.5

12

66

N. S.

30.0

8

100

N. S.

2.0

10

70

N. S .

At r opine

'P
•
.-eserpine

2

dl-3 , 4 -dihyd r oxyphenylalani n e
01 - 5-hyd ro xytrypto phan
Ci1lorproma zine

3

4

3

SyrosingopineG
H;droxyamphetamine3
Amphetaminc3

N. S.

N

Roserpine +
dl-3, 4-d:ihydroxyphenyla la nine +
a l·-5-hyd

ox~·1...rr-itophan

Am;?hetamire

---

+

3. 0
400.0
75.0
2.0

CD

8

50

L .o5

TABLE VIII (continued)

145 min prior to performance.
2
3

4

24 h prior to performance.
30 min prior to performance.

1 h prior to p erformance.

5 6 0 min prior to performance.
6 4 h prior to p e rformance.

N
\.0
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Role of Central and Periph eral l\rnine Stores
If central catecholamine s and/or 5-hydroxytryptamine are
required for the amphetamine-state to occur, than reserpine,
a central and peripheral amine depleting drug (Pl etcher

et_~-,

1955; Holzbaurer and Vogt, 1956), should prevent the restoration of the amphetamine-state.

Syrosingopine, ·a periphera 1

amine depletor (Garrattini, 1959), should cause a decrement
in amphetamine state only if peripheral amines are involved
in the stimulus-state.

Further, if only catecholamines are

necess ary for the amphetamine-state, then dl-3,4-dihydroxyphenylalanine, a precursor of catecholamines (Gurin and
Delluva, 1947), should reverse the effect of reserpine.

On

the other hand, if 5-hydroxytryptamine is responsible for the
amphetamine-state, than dl - 5-hydroxytryptophan, a precursor of
5-hydroxytryptamine (Carlesson et al., 1963), should restore
the amphetamine effect in reserpinized animals.

If both

norepinephrine and 5-hydroxytryptamine are needed for the
amphetamine-state, then both dl-3,4-dihydroxyphenylalanine
and dl-5-hydroxytryptophan will be necessary to alleviate the
effect of reserpine.
Data summarized in Table IX indicate that amphetaminetreatecl animals, when tested under reserpine and amphetanine
(A-R+A); or reserpine, dl-3,4-dihyd::-ox /phcny L:ilaninc and
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amphetamine (A-R+D+A); or reserpine, dl-5-hydroxytryptophan
and amphetamine (A-R+SHTP+A), showed a significant decrement
in avoidance.

However, testing amphetamine-trained animals

under reserpine, dl-3,4-dihydroxyphenylalanine, dl-5-hydroxytryptophan and amphetamine {A-R+D+SHTP+A) results in no decrement in avoidance.

Further, no decrement in per cent avoidance

is seen when amphetamine-trai ned animals are tested under
syrosingopine and amphetamine (Table IX, A-S+A).

Moreover,

a significant difference in per cent avoidance is seen when
amphetamine-trained animal s tested under syrosingopine and
amphetamine or reser pine, dl-3,4-dihydroxyphenylalanine, dl5-hydrox ytryptoph an , and amphetamine, are compared to similarly
trained animals tested under reserpine and amphetamine
(A-R+D+SHTP+A, A-S+A vs A-R+A, P

L_ .01); reserpine, dl-5-

hydroxytryptophan and amphetamine (A-R+D+SHTP+A, A-S+A vs
A-R+SHTP +A, P

~

.01); or reserpine, dl-3,4-dihydroxyphenylal-

anine and amphetamine (A-R+5HTP+D+A, A-S+A vs A-R+D+A, P

~

. 01) .

No difference in per cent avoidance is seen when amphetaminetrained animals tested under syrosingopine and amphetamine
are compared to similarly trained animals tested under r es e rpine, dl-3,4-dihydroxyphenylalanine, dl- 5 -hyd roxytryp to phun
and amphetami n e (l\-S+A vs A-R+D+5HTP+A, P

~·~

. 05) .

In a ddi ti on,

no significant dif fe rence i n per cent a v oidance occurs between

TABLE IX
EFFECT OF RESERPINE AND SYROSINGOPINE ON CONDITIONED AVOIDANCE
RESPONSES ACQUIRED UNDER AMPHETAMINE

p

Treatment Prior to
Performance

N

!\-A

Amphetamine 1

15

80

A-R+A

Reserpine 2 +
Amphetamine

8

13

t

A-R+D+A

Reserpine + dl-3,4dihydroxyphenylaline 3 +
Amphetamine

16

31

,.01 6

A-R+SHTP+A

Reserpine + dl-54
hydroxytryptophan +
Amphetamine

24

54

~. 05 7

A-R+SHTP+
D+A

Reserpine + dl-5hydroxytryptophan +
dl-3,4-dihydroxypheny lalanine +
Amphetamine

15

66

N .S.

15

80

N.S .

Group

A-Syr+A

.
.
5
Syros1ngop1ne +
Amphetamine

%
Avoidance

Acquisition vs Performance

N .S.

.01

w
IV

TABLE IX (continued}
1 2.0 mg/kg, i.p., 30 min prior to performance.
2

3.0 mg/kg, i.p., 24 h prior to performance.

3400 mg/kg, i.p., 15 min prior to performance.
4

75 mg/kg, i.p., 1 h prior to performance.

52 . 5 mg/kg, i.p., 4 h prior to performance.
6 88% avoida nce during last acquisition trial.
796% avoidance during last acquisition trial.

w
w
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amphetamine-trained animals tested under reserpine, dl-3,4dihydro xyphcnylalanine, dl-5-hydro xytryptophan and amphetamine and no-drug trained animals tested under no-drug
(A-R+D+5HT P+A vs ND-ND).

The combination of reserpine and

dl-3,4-dihydroxyph enylalanine, dl-5-hydroxytryptophan and
amphet amine resulted in a significant decrement (Table XII,
P

~

. 05) in avoidance in a newly acquired conditioned

avoidanc e response.
If a catecholamine, i.e. norepinephrine, released by
amphetamine (Car r and Moore, 1969) is responsible for the
amphetamine-stat e , than dl-3,4-dihydroxyphenylalanine should
substitute for amphetamine.

Similarly, if 5-hydroxytrypt-

amine is responsible for the amphetamine-state, than dl-5hydroxytryptophan should substitute for amphetamine.

Data

presented in Table X indi cate that, while dl-3,4-dihydroxyphenylalanine subst ituted for amphetamine (A-D), a significant decrement in per cent avoid ance is noted when amphetamine-trai ned animals are tested under dl-5-hydroxytryptophan,
(A-5HTP) .

Role of Amine Synthesis
In order to determine if catecholamines, required for
amphe tamine-stat8, are new] y synthesized or that which is
stored, dl- &. -methyl- p-tyrosine, an inhibitor of catechol -
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amine synthesis (S pector et

~. ,

1956) was used.

The time and

dose were so selected (Rech et al., 19 68) as to allow inhibition of synthesis without
amines.

depletion of the stored catechol-

If newly synthesized norepinephrine is needed, than

pretreatment under

dl-~-methyl-p-tyrosi ne

should cause a

decrement in amphetamine-trained animals tested under amphetamine.

Replacing the catecholamines by administering dl-3,4-

dihydroxyphenylalani ne should alleviate this decrement.
Similarly, if 5-hydroxytryptamine is involved in the

am~1et

amine-state, than p arachl orophenylalanine, an inhibitor of
5-hydroxytryptamine synthesis (Koe and Weissman, 1966),
should prevent the amphetam ine-state from occuring.

Replacing

the 5-hydroxytryptamine, by administering dl-5-hydroxytryptophan, should reverse the effect of parachlorophenylalanine.
Data presented in Table X show that pretreatment with
dl-d-methyl-p-tyrosine caused a decrement in amphetaminetrained animals when tested under amphetamine (A-MPT+A).

The

dl-3,4-dihydroxyphenylalan ine alleviated the decrement caused
by the

dl-~-methyl- p-tyrosine.

A si gnificant difference in

pe r cent avoidance is seen if amphetamine-trained animals,
tested under amph etamine, after pretreatment under dl-dmethyl-p-tyrosine, are compared to similarly trained animals
tested und er dl-3,4-dihydroxyphenylalanine and amphetamine
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after pretrc<1trncnt under dl- 0 L-rncthyl-p-tyrosine (A-·MPT+A vs
A-MPT+D~~,

(P

.(

P

~

.01).

Moreover, a significant difference

. 05) in per cent avoidance is seen when arnphetarnine-

tra ined animals were tested under dl-3,4-dihydroxyphenylalanine and comp3red to amphetamine-trained animals tested under
amphetamine and dl-C\-methyl-p-tyrosine (A-D vs A-MPT+A, P

c( . 05).

Performance of amphetamine-trained animals tested under dl-3,4dihydroxyphenlalanine was not significantly different from
similarly trained animals tested under dl- t<.-methyl-p-tyrosine,
dl-3,4-dihydroxyphenlalanine and amphetamine (A-D vs A-MPT+
D+A

I

p

7 . 05 ) .

Data in Table X also indicate that parachlorophenylal-anine caused a decrement in per cent avoidance in amphetaminetreated animals (A-PCPA+A).

However, dl-5 -hydroxytryptophan

alleviated the decrement caused by the parachlorophenylalanine (A-PCPA+5HPT+A).

Further, a significant difference in

per cent avoidance is seen when amphetamine-trained animals
were tested under parachlorophenlalanine, dl-5-hydroxytryptophan and amphetamine and were compared to similarly trained
animals but tested under either dl-5-hydroxytryptophan alone
or parachlorophenylalanine and aml:Jhetamine (A-PCPA+5IITP+A vs
A-5HTP or A-PCPA+A, P

<

.05).

TABLE X
EFFECT OF P-CHLOROPHENYLALANINE AND DL-oL-METHYL-P-TYROSINE ON
CONDITIONED AVOIDANCE RESPONSES ACQUIRED UNDER AMPHETAMINE

Group

Treatment Prior to
Performance
1

N

%
Avoidance

p

Acquisition vs Performance

15

80

N.S.

dl- "-Methyl-p-tyrosine 2 +
Amphetamine

32

28

.! . 01

A-MPT+D+A

dl- ~ -Methyl-p-tyrosine +
dl-3,4-dihydroxyphenylalanine 3 + Amphetamine

9

78

N. S.

A-D

100

dl-3,4-dihydroxyphenylalanine3

12

75

N.S.

400

dl-3,4-dihydroxyphenylalanine4

13

92

N.S.

12

41

~ .05

12

86

N .S.

A-A

Amphetamine

A-MPT+A

A-D

A-PCPA+A

A-PC PA+
SHTP+A

5
Parachlorophenylalanine +
Amphetamine
Parachlorophenylalanine +
dl-5-Hydroxytryptophan 6 +
Amphetamine

w
-...)

TABLE X (continued)

A-5HTP75

dl-5-Hydroxytryptophan

6

12

25

A-5HTP150

dl-5-Hydroxytryptophan 7

12

16

l

.01
/,. .01

8

12.0 mg/kg, i.p., 30 min prior to performance.
2

50 mg/kg, i • p

2 h prior to performance.

•I

3 100 mg/kg,
i •P

•I

30 min prior to performance.

4 400 mg/kg,
i •P

•I

30 min prior to performance.

5 316 mg/kg, i • p •
6 75 mg/kg, i • p

•I

I

3 days prior to performance.
30 min prior to performance.

7 150 mg/kg, i.p., 30 min prior to performance.
8 92% avo i dance during last acquisition trial.

w
OJ
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Amphetamin e -State

A~ter

I_nhibition of

Catech olamine-Sy~1thcsi~

If animu ls arc t ra incd ancl tcs Lccl un rlcr dl- c~ -mclhy 1-ptyrosine and amphetamine wi t hout showing any decrement in per
cent avoidance, than catecholamine synthesis may not be absolutely necessary for the amphetamine-state.

Data swnrnarized

in Table XI indicate that animals trained under amphetamine
after pretreatment under dl-G.{-methyl-p-tyrosine, when
tested under amphetamine after pretreatment under dl-Jmethyl-p-tyrosine {MPT+A-MPT+A) or no pretreatment {MPT+A-A)
showed no decrement in avoidance.

Similarly trained animals,

when tested under no-drug {A-MPT-ND), showed a decrement in
avoidance.
avoidance {P

There was a significant difference in per cent
~

.01) between the animals trained and tes ted

under dl- c(-methyl-p-tyrosine and amphetamine and the amphetamine-trained animals tested under dl-J--methyl-p-tyrosin e
and amphetamine {MPT+A-MPT+A vs A-MPT+A).

Role of Amine Receptors
If noradrenergic receptors are involved in the amphetamine-state, than chlorpromazi ne, a central adren ergic
blocking agent {Douglas, 1965), should cause a decrement in
amphetamine-state.

Similarly, if serotoninergic receptors

are involved in the

a m~1etamine -st ~te ,

than cyproheptadine,

a serotoninergic blocking agent {Stone et_ tl·, 19 61 ), should

TABLE XI
EFFECT OF AMPHETAMINE AND DL-~-METHYL-P-TYROSINE
ON CONDITIONED AVOIDANCE RESPONSES

%
Avoidance

p

Acquisition

Performance

N

Amphetamine 1

Amphetaminel

10

80

N. S.

MPT+AMPT+A

dl- / .. -Methyl-ptyrosine 2 +
Amphetaminel

dl- / ... -Methyl-ptyrosine 2 +
Amphetamine 1

32

72

N. S.

MPT+A-

dl- J.-Methyl-ptvrosine 2 +
A~phetaminel

Amphetamine 1

17

76

N .S.

dl-at-Methyl-ptyrosine 2 +
1
Amphetamine

No Drug

9

0

Amphetamine 1

dl- ef.. -Methyl-ptyrosine 2 +
Amphetaminel

32

28

Group

A-A

A

MPT+A~'D

A-MPT+
A

Acquisition vs Performance

~ .001

~.

01

1 2.0 mg/kg, i.p., 30 min prior to performance.
2

so

mg/kg, i.p., 2 h prior to performance.

~

0
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cause a decrement in amph etamine-state.

Data presented in

Table XII show tha t amphetamine-trained animals when tested
under amph etamine after pretreatment with chlorpromazine
(A-CPZ+A), cyproheptadine (A-Cyp+A), o r atropine (A-At+A)
exhibited significant decrement in avoidance.
significant differenc e (P "

Further, a

.01) is seen when amphetamine-

treated animals tested under amphetamine are compared to
similarly trained ani mals t 8sted under a combination o f
chlorpromazine and amphetamine (P
and amphetamine
(P

~

. 01)

I

(A

(P
VS

4'. . 01), cyproheptadine

<!.Ol), or atropine and amphetamine
CPZ+A

I

Cyp+A

I

At +A ).

TABLE XII
EFFECT OF CHLORPROMAZINE, CYPROHEPTADINE AND ATROPINE ON CONDITIONED
AVOIDANCE RESPONSES ACQUIRED UNDER AMPHETAMINE

Group

Treatment Prior to
Performance

Amphetamine

A-A

1

N

%
Avoidance

p

Acquisition vs Performance

10

80

N. S.

A-CPZ +A

Chlorpromazine 2 +
Amphetamine

14

36

£.01

A-CPZ +A

Chlorpromazine 3 +
Amphetamine

10

20

~

A-Cyp+A

Cyproheptadine 4 +
Amphetamine

10

30

£ .os 6

li.-At+A

Atropine 5 +
Amphetamine

24

48

l. . 01

1

2

1 2.0 mg/kg, i • p
2

3

•I

30 min prior to performance.

i •P

•I

45 min prior to performance.

4.0 mg/kg, i • p

•I

45 min prior to performance.

1. 0 mg/kg I

4 10 mg/kg,
i.p
5

.01

~

N

60 min prior to performance.

•I

5.0 mg/kg, i • p •

I

45 min prior to performance.

6 90% avo·dance during last acquisition trial.

V.

DISCUSSION

While animals trained under 0.5 or 1.0 mg amphetamine
per kg body weight showed a decrement in avoidance when tested
under corresponding doses of amphetami ne , anima ls trained and
tested under 2.0 mg amphetamine per kg body weight showed no
decrement in avoidance.

Using the latter dose of amphetamine,

the drug-trained anima ls showed a decrement in avoidance when
tested under no-drug (Figu re l, Table II).

Thus amphetamine,

in a dose of 2.0 mg/kg, p r oduces a stimulus-state which is
capable of controlling avoidance behavior.

The anima ls which

are trained under no-drug and tested under no-drug in four
consecutive daily tests showed marked decrement in avoidance
in all of the te sts (ND-ND, Tests 1 to 4, Table III).

However,

this decreme nt may have been due to a weaker learning since
in a previous study, mice, trained to a stronger criterion
under no-drug, showed no decrement in avoidance when tested
under no-drug (Lal, 1969) .
Since testing of no-drug trained animals under amphetamine resulted in no decrement in avoidance (ND-A

1-4

, Table

III), then the stimulus-state produced by amphetamine is in
only o ne dir ec tion, drug to no-drug.

This type of stimulus
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control has been called asymet ric al <lissociiltion of learn ing
(Overton, 1968).

Berger and Stein (19 69 ) explained the

asymetry by a neurological model.

According to th ese workers,

the brain is chemically differentiated into two hypothe tic al
subsystems; a functionally dominant subsystem that can be
affected by the action @f drugs and a subordinate subsy s tem
that can resist the action of these drugs.

The drug treated

animal s acquire a task in the subordinate subsystem becau se
the dominant subsystem is blocked by the drug.

Testing these

animals under no-drug will result in little, if any, demonstration of learn ed behavi or because the dominant subsystem
would prevail ove r the subordinate subsystem which acted as
a substitute.

Since amphetamine has not been shown to be

either an alpha or beta central nervou s system blocking agent,
this model does not adequately explain the asymetrical
dissociation described in this report.

The strength of the

drug-stimulus may determine whether its stimulus control of
behavior is symetrical or asymetrical.

Lal (1969) has

recently shown that mice, trained under no-drug, showed a
de c rement in avoidance when tested under chlorpromazine
while similarly trained mice showed no decrement in avoidunce
when tested under amphetamine.

However, testing chlorpro-

mazine or amphetamine-trained mice under no-drug, resulted
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in a decrement in avoidance.

The symctrica.l dissociation

obtained under chlorpormazine may be due to the stronger
stimulus-state produced by that drug, while lhe u.symetrical
dissociation, obtained under amphetamine, is probably the
result of a weak stimulus-state.
The lack of decrement in animals trained under no-drug
and tested under amphetamine (ND-.l\

1-4

, Table III) may be

interpreted as clue to the stimulant property of amphetamine.
However, animals tested under a similar dose of drug, but
trained to a weaker criteria, also showed a decrement in
avoidance (Table V).

Thus, it is unlikely that avoidance

under amphetamine was only due to the stimulant property of
the drug.

Moreover, if the avoidance-responses were mere

manifestation s of locomotor stimulation, th en animals treated
under amph etamine would show great er number of avoidance
r esponse s on the first trial of the acquisition phase.
such first trial avoidances were observed (Table V).

N·'.)
Further,

if the amphctam i!1e-s tatc did not exist then no differenc e in
per c ent avo ida nce should exist between arnph ctamine- tra ined
animals tested u nder no- dr ug and no-drug trained animal s
tested under no-drug (A- ND vs ND-ND).
is a si9n ificant diffcreitce (P

<"'

On the contr<.iry, th e re

.05) in th n:.:c out of the
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A-ND

vs ND-ND ).
4

4

Thus, the stimulant-state, produced by

amphetamine, is not the result of the motor stimulant action
o f the drug .
If amphetamine-associated learning is due to the novelty
of action of the drug, then by treating the animals chronically with the drug, this effect should be eliminated.

In

experiments using chronically treated amphetamine-trained
animals , tested under amphetamine, no decrement in avoidance
was seen (A -A ), while similarly trained animals tested under
c
no-drug showed a decrement in avoidance (A -1-.TD).
c

In addition,

these animals, when trained and tested under no-drug (ND -ND)
c

showed no decrement in avoidance (Table VII).

I

The good

avo idance seen in the latter group was probably the result of
a greater contrast between drug and no-drug states.

The

strengthened state, ,which was due to the lack of an amphetamine injection, may have b een equivalent to a stronger
training criteria.

However, the lack of decrement observed

when no-drug trained animals were tested under amphetamine
could be due to the insufficient stimulus produced by amphetamine.
Animals trained under hydroxyamphetamine,

30 mg/kg, s:1m c d

no decrement in avoidance when tested unc1er the same dos0. of
that drug (Table IV, OTIA

30

-ORA

30

).

However, this leu.rning is
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associated with no apparent drug-state as there was no dccrernent in response strength when hydroxyamphetamine-trained
animals were tested under no-drug (Table IV, OHA

30

-ND)

o

Since

hydroxyamphetamine, which has little central action (Innes and
Nickerson, 1969) could not substitute for amphetamine and since
reserpine, but not syrosingopine, caused a decrement in
amphetamine-trained animals, then the amphetamine-state is
central in nature and requires central amines.
Since chlorpromazine, cyproheptadine or atropine caused
a decrement in avoidance in amphetamine-treated animals
(Table XII, A-CPZ+A, Cyp+A, A-At+A), then the action of catecholamines, 5-hydroxytryptamine or acetylcholine may be invalved in the amphetamine-state.

However, atropine has been

shown to block the increase in free operant avoidance in
amphetamine-treated animals (Goldberg and Ciolfolo, 1969).
Thus, the decrement in avoidance in the atropinized animals
may be the result of a direct depressant effect on the central
nervous system by the drug.

Therefore, acetylcholine may not

be involved in the amphetamine-state.
The dl-3,4-dihydroxyphenylalanine, which alleviated the
decrement in avoidance produced by dl-J. -methyl-p-tyrosine
(Table X, A-MPT+A, A-MPT+D+A) was also found to substitute
for amphetamine(Table X, A-D).

These results indicate that
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catecholamines are invoJ ved in the amphetamine-state.

However,

animals pretreated under dl c;l-methyl-p-tyrosine and trained
under amphetamine showed no decrement in per cent avoidance
when tested under either amphetamine or amphetamine after
pretreatment under dl-J...-methyl-p-tyrosine (MPT+A-A, MPT+AMPT+A, Table XI).

Therefore, animals trained without pre-

treatment of dl- 0t-methyl-p-tyrosine are likely to utiliz e
both newly synthesized as well as previously stored catecholamines for release by amphetamine in their stimulus-state.
Reduction of the catecholamines synthesis, in these animals,
will prevent restoration of this stimulus-state . . However, in
animals trained with reduced catecholamines synthesis, amphetamine probably utilized previously synthesized catecholamines
to produce the stimulus-state.

Restoration of the amphetamine-

state can occur with either greatly reduced or usual synthesis
of catecholamines.

Thus, while some released catecholamines

seems to be essential for the amphetamine-st ate, the amount
of catecholamines available for releas e, during trai ning, may
determine the amphetamine-state.
The result s under 5-hydroxytryptamine seem at first somP.what confusing.

The decrement in avoidance when

amphetamir~

trained animals are tested under amphetamine after parachlorophenylalanine pretreatment indicates that some indolealkyl-
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amines are involved in the amphetamine-state.

Further, the

fact that administered dl-5-hydroxytryptoph an , which is taken
up by nerve endings (Rodriguez De Lores Arnaiz and De Robertis,
1964) and converted to 5-hydroxytrypt amine

(Carlsson et al.,

--

1963}, alleviated the decrement in avoidance produced by
parachlorophenylalanine, also indicated that indolealkylamines
are involved in the stimu lus- state (Table X, A-PCPA+A, APCPA+5HTP+A).

In contrast the decrement in per cent avoidance

due to substitution of dl-5-hydroxytryptophan for amphetamine
(A-5HTP) _indicate s that indolealkylaminesmay not be involved
in the amphetamine-stat e .

However, dl-5-hydroxytryptophan

has been demonstrated to depress shock avoidance in rats
(Aprison and Hingtgen, 1966).

Therefore , excess 5-hydroxy-

tryptamine which occur s while testing under dl-5-hydroxytryptophan, probably depresses some parts of the central
nervous system.

The reason that dl-5-hydroxytryptophan is

able to alleviate the decrement produced by parachlorophenylalanine is that the latter depresses 5-hydroxytryptamine
synth esi s

so that there is no excess 5-hydroxytryptamine.

In addition, if some either sub stance , i.e., amphetamine, or
catecholamines was required for the release of 5-hydroxytryptamine , then in the absence of this substance, the 5hydroxytryptamine would remain within the n erve , and not be
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released to produced the amphetamine-state.

Since amphetamine

has been shown to ralease 5-hydroxytryptaminc only in doses
exceeding those used in behavioral studies (Beauvallet et al.,
1969), it is unlikely that amphetamine directly releases 5hydroxytryptamine.

Rather, amphetamine probably releases

catecholamines (Glowinski et al., 1966b; Carr and Moore, 1969),
which in turn releases 5-hydroxytryptamine thereby producing
the stimulus-state.

These results are consistent with the

findings of Lal et al.,

(1969), in which they hypothesized

that 5-hydroxytryptamine acting through catecholamines is
responsible for raising the shock level necessary for shock
induced fighting.

V.

1)

CONCLUSIONS

Amphetamine was shown to produce an asymetric stimulusstate which can control conditioned avoidance responses.

2)

The amphetamine-state was not based upon a novel drug
stimulus.

3)

The amphetamine-state depended upon the central catecholamines primarly norepinephrine acting through central
serotonin.

4)

.

The level of available catecholamines determined the
amphetamine state.

5)

Hydroxyamphetamine did not produce a stimulus-state which
can control behavior.
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